TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies July 13, 1984
TCL Archive NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies March 8, 2013
TCL Archive DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer October 28, 1983
